Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells.
about
Big Data Offers Novel Insights for Oncolytic Virus ImmunotherapyCirculating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinomaFavorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG.Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) is associated with immune phases of patients with chronic hepatitis B.Present and future therapies of hepatitis B: From discovery to cureHepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent MechanismUnique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection.Advances in therapeutics for chronic hepatitis B.Peripartum cytokine flares in a multiethnic cohort of chronic hepatitis B carriers does not correlate with hepatitis B virus suppression or increased risk of liver disease.Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes.The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.Differential expression of innate immune response genes in clinical phases of chronic hepatitis B infection.Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.Mucosal-associated invariant T (MAIT) cells are more activated in chronic hepatitis B, but not depleted in blood: reversal by antiviral therapy.Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment.Memory Regulatory T cells Increase Only In Inflammatory Phase of Chronic Hepatitis B Infection and Related to Galectin-9/Tim-3 interaction.The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.Humoral immunity, the underestimated player in hepatitis B.Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes.Human immunodeficiency virus and liver disease: A comprehensive update.PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection
P2860
Q26767209-D496A02C-75FF-41A4-8942-D7D11355299FQ28080175-09610F72-4D89-4423-A850-BAB1B1B729F3Q33694522-39C2BDB1-F37F-49A2-874A-3278FD2E0955Q33761546-957A110A-FA56-4A4A-A765-A32157BE7A30Q36378278-CE746C7F-BF84-4FD9-A8FA-FA10C6A9949BQ37073307-405916F7-6A62-43EC-9862-DFB071732E37Q38373475-9CB61C8B-A0F8-4EF0-8058-4F2680787C7AQ38585657-DCF02248-AA57-46EA-A7DE-CCED53945FAAQ38764042-898F644F-61CD-4CC3-AD9C-4AFE6A90C969Q38825971-C986F7BF-12F4-44B6-8F24-E84CCC65BD2CQ39008629-4B21BC0C-4100-41C0-B6FF-FB1272E0EC4BQ40325365-A8498963-AF45-41B5-8AA8-D5D4F0BC9D03Q40722555-F00FDA8B-B697-4513-9774-7E3AB9E8397FQ41926537-59DD85D4-2672-40E6-81F0-D0CB8BD1ABD1Q45325450-8EABD60B-1D6D-4E5F-A860-33309D15093BQ46520709-BAE1812B-5D09-481F-AD3F-E59E29D53019Q47355500-4AB231D8-2301-45BC-8608-9A2C0AEC2CFAQ49962982-5CFB93F4-9B6A-4B2D-9845-4E4343B2E56EQ54263472-4EDC7212-079D-4827-B867-E53A33037828Q55109199-67D9E2BB-F783-4D62-BC17-6C014CB3A5F8Q57201477-BBCA923B-4EA5-4C91-AEA2-5352AC131007
P2860
Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Re-evaluation of hepatitis B v ...... e immune response and B cells.
@en
type
label
Re-evaluation of hepatitis B v ...... e immune response and B cells.
@en
prefLabel
Re-evaluation of hepatitis B v ...... e immune response and B cells.
@en
P2093
P2860
P356
P1433
P1476
Re-evaluation of hepatitis B v ...... e immune response and B cells.
@en
P2093
A D M E Osterhaus
Arno C Andeweg
Gertine van Oord
Harry L A Janssen
Suzan D Pas
Thomas Vanwolleghem
P2860
P304
P356
10.1002/HEP.27805
P407
P577
2015-04-27T00:00:00Z